Stifel Jaws & Paws Conference 2026
Logotype for Elanco Animal Health Incorporated

Elanco Animal Health (ELAN) Stifel Jaws & Paws Conference 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Elanco Animal Health Incorporated

Stifel Jaws & Paws Conference 2026 summary

27 May, 2026

Conference overview

  • The event featured 22 companies, four physician panels, and an animal health industry discussion over two days, with a focus on innovation and market trends in animal health.

  • Key sessions included updates on product launches, pricing strategies, and market growth across pet and farm animal segments.

Market and industry trends

  • Animal health market is growing durably, with 7% overall growth last year; farm animal grew 10%, pet 5%.

  • Pet care spending remains resilient, with consumers prioritizing pet health over other discretionary expenses.

  • Pricing remains strong and stable, with no significant discounting or price-based competition observed.

  • Increased investment in direct-to-consumer (DTC) marketing is being used to maintain market share.

Product innovation and launches

  • New products like Zenrelia and Credelio Quattro are driving growth, with Zenrelia achieving blockbuster status and over 50% U.S. clinic adoption.

  • Befrena monoclonal antibody launch is underway, with strong early interest from veterinarians and expected to contribute significantly in 2027.

  • Credelio Quattro is gaining share, now present in 40% of clinics and achieving 53% share within those clinics.

  • Global expansion of key products is ongoing, including launches in Australia and Japan.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more